Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

AC Immune SA (ACIU)

7.07   0.2 (2.91%) 07-07 13:59
Open: 6.9 Pre. Close: 6.87
High: 7.17 Low: 6.84
Volume: 18,520 Market Cap: 508M
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops therapeutic and diagnostic products for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectively interact with misfolded proteins that are common in a range of neurodegenerative diseases. The company's lead product candidate is crenezumab, a humanized, monoclonal, and conformation-specific anti-Abeta antibody, which is in Phase II clinical prevention trial for the treatment of Alzheimer's disease (AD).

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 7.078 - 7.116 7.116 - 7.147
Low: 6.683 - 6.725 6.725 - 6.76
Close: 6.802 - 6.872 6.872 - 6.933

Technical analysis

as of: 2020-07-07 1:24:20 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 8.64     One year: 10.10
Support: Support1: 6.86    Support2: 6.52
Resistance: Resistance1: 7.40    Resistance2: 8.64
Pivot: 6.93
Moving Average: MA(5): 6.92     MA(20): 6.91
MA(100): 7.02     MA(250): 6.81
MACD: MACD(12,26): -0.06     Signal(9): -0.09
Stochastic oscillator: %K(14,3): 58.65     %D(3): 50.21
RSI: RSI(14): 52.54
52-week: High: 10.14  Low: 4.07  Change(%): 29.7
Average Vol(K): 3-Month: 8393  10-Days: 5422

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
ACIU has closed below upper band by 25.9%. Bollinger Bands are 69.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to ACIU's normal range. The bands have been in this narrow range for 12 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 07 Jul 2020
Tau-PET Tracer PI-2620 Could Set New Standards for an Improved Diagnosis of Progressive Supranuclear Palsy - GlobeNewswire

Tue, 07 Jul 2020
How Much Of AC Immune SA (NASDAQ:ACIU) Do Insiders Own? - Yahoo Finance

Sat, 04 Jul 2020
Hedge Funds Have Never Been This Bullish On AC Immune SA (ACIU) - Yahoo Finance

Fri, 26 Jun 2020
AC Immune Announces Results of Annual General Meeting - GlobeNewswire

Sat, 20 Jun 2020
Data Readouts Due This Month - Do You Have These Pharma Stocks In Your Portfolio? - Nasdaq

Wed, 06 May 2020
AC Immune SA (NASDAQ:ACIU) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates - Yahoo Finance

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 72
Shares Float (M) 27
% Held by Insiders 47.90
% Held by Institutions 26.78
Shares Short (K) 616
Shares Short P. Month (K) 599

Stock Financials

EPS -0.550
EPS Est This Year -0.620
EPS Est Next Year -0.720
Book Value (p.s.) 2.990
Profit Margin -53.36
Operating Margin
Return on Assets (ttm) -4.8
Return on Equity (ttm) -10.2
Qtrly Rev. Growth -83.5
Gross Profit (p.s.) 0.843
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio -12.87
PEG Ratio
Price to Book value 2.37
Price to Sales
Price to Cash Flow

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.